HOME >> MEDICINE >> NEWS
Society lauds FDA menopausal hormone therapy information campaign

Washington, D.C. -- The Society for Women's Health Research (SWHR) joins other health organizations today in praising the U.S. Food and Drug Administration's (FDA) menopause information campaign, designed to help women make informed decisions about using combination hormone therapy (estrogen and progestin) in the wake of uncertainty about such drugs.

"This is an important first step, but there are still many unanswered questions about hormone therapy, dosage and delivery options," Sherry Marts, Ph.D., SWHR vice president for scientific affairs, said. "Clearly more research must be done in order to provide women with other treatment options for relief of menopausal symptoms and prevention of bone loss."

"Today, an estimated ten million postmenopausal women in the U.S. use combination hormone therapy products, while others have chosen not to. No matter which alternative women choose, they should have the best information available as they make the decision for their own, individual health," she said.

Launched this month, the FDA campaign provides women with the following:

  • General information about benefit and risk factors of menopausal hormone therapy.
  • Questions that women can ask in discussion with their health professional to determine if menopausal hormone therapy is right for them.
  • Actions women can take to improve their overall health.

Information is available in both English and Spanish from the National Women's Health Information Center (NWHIC) at www.4woman.gov.


'"/>

Contact: Amy Hoskins
amy@womens-health.org
202-496-5015
Society for Women's Health Research
9-Sep-2003


Page: 1

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. The European Society of Cardiology launches Women at Heart
3. American Thoracic Society Journal news tips for March 2005 (second issue)
4. AACC and The Endocrine Society partner to promote patient education
5. ENDO 2005 - The Endocrine Societys 87th annual meeting
6. American Thoracic Society Journal news tips for March 2005 (first issue)
7. Society of Hospital Medicine to launch new medical journal
8. Society for Research in Child Development (SRCD) biennial meeting
9. American Thoracic Society Journal news tips for February 2005 (second issue)
10. American Thoracic Society Journal news tips for February 2005 (first issue)
11. American Thoracic Society Journal news tips for January 2005 (second issue)

Post Your Comments:
(Date:5/24/2013)... 2013 According to the National Institutes of ... epidermal necrolysis (TEN) that affects the skin and mucous membranes. ... under the age of 30 (i). In the early ... fever. As SJS advances, it affects the mucous membranes ... anus. Inflammation of the eye causes conjunctivitis (pink eye). ...
(Date:5/24/2013)... BEACH, CA (PRWEB) May 24, 2013 ... health care education community, proudly participated in festivities surrounding ... April 19-21. The event provided the perfect backdrop to ... facilities at 236 E. 3rd Street, housed in an ... Arts Building. , ACC was an active exhibitor throughout ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- About one in ... their teens take up smoking, drinking or illicit drug ... too bad, say experts at the Substance Abuse and ... that parents are actually one of the most influential ... issues. "Surveys of teens repeatedly show that ...
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... youth and diabetes keeps getting worse. The latest data from ... Type 2 diabetes are at high risk to develop heart, ... than people who acquire Type 2 diabetes as adults. ... to be at very high risk for early complications when ... endocrinology in the School of Medicine at The University of ...
Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Youth with type 2 diabetes at much higher risk for heart, kidney disease 2
(Date:5/24/2013)... and BOSTON , May 24, 2013 /PRNewswire/ ... development company, is pleased to announce that it has engaged Mr ... the Company,s business development capabilities in Japan ... 15 years of experience in business development, licensing and alliance management ... Roche Pharma ( Japan ), Nippon Roche and Tanabe ...
(Date:5/23/2013)... DIEGO y PARÍS, 24 de mayo ... VOLC ), un destacado desarrollador y fabricante de ... mejorar la diagnosis y tratamiento de la enfermedad ... preliminares del ensayo ADVISE ( Ad enosine ... E valuation) II durante la sesión de ...
(Date:5/23/2013)... May 23, 2013  Haemonetics Corporation (NYSE: HAE ... CFO & EVP-Business Development, will present at The Deutsche Bank ... Boston, MA on May 29, 2013 at ... ) The public may access Mr. Lindop,s presentation ... About Haemonetics Haemonetics (NYSE: HAE ) ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
Cached News: